Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-004306
Filing Date
2008-05-21
Accepted
2008-05-21 17:26:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. - FORM S-1/A g06286b1sv1za.htm S-1/A 107908
2 EX-10.3.1 SECOND AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT g06286b1exv10w3w1.htm EX-10.3.1 16513
3 EX-10.6.1 THIRD AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT g06286b1exv10w6w1.htm EX-10.6.1 17420
4 EX-10.9.1 AMENDMENT TO KIRISTALOSE AGREEMENT g06286b1exv10w9w1.htm EX-10.9.1 7764
5 EX-10.16.4 THIRD AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT g06286b1exv10w16w4.htm EX-10.16.4 17594
6 EX-10.21.1 FIRST AMENDMENT TO OFFICE LEASE AGREEMENT g06286b1exv10w21w1.htm EX-10.21.1 36053
7 EX-10.24.1 SECOND AMENDMENT TO AMENDED AND RESTATED LEASE AGREEMENT g06286b1exv10w24w1.htm EX-10.24.1 6447
8 EX-10.25 MANUFACTURING AGREEMENT g06286b1exv10w25.htm EX-10.25 109996
9 EX-23.1 CONSENT OF KPMG LLP g06286b1exv23w1.htm EX-23.1 2675
10 GRAPHIC g06286b1g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-08-004306.txt   324344
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 08852578
SIC: 2834 Pharmaceutical Preparations